| Opportunity ID: |
325184 |
| Opportunity Number: |
NOT-CA-20-028 |
| Opportunity Title: |
Notice of Intent to Publish a Funding Opportunity Announcement for Metastasis Research Network (U54 Clinical Trial Not Allowed) |
| Opportunity Category: |
Discretionary |
| Opportunity Category Explanation: |
|
| Funding Instrument Type: |
Cooperative Agreement |
| Category of Funding Activity: |
Health |
| Category Explanation: |
|
| CFDA Number(s): |
93.393
93.394
93.395
93.396
93.399 |
| Eligible Applicants: |
State governments
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: |
|
| Agency Code: |
HHS-NIH11 |
| Agency Name: |
Department of Health and Human Services
National Institutes of Health |
| Posted Date: |
Mar 05, 2020 |
| Last Updated Date: |
Mar 05, 2020 |
| Estimated Synopsis Post Date: |
Apr 15, 2020 |
| Fiscal Year: |
2021 |
| Award Ceiling: |
$1,500,000 |
| Award Floor: |
|
| Estimated Total Program Funding: |
$7,500,000 |
| Expected Number of Awards: |
5 |
| Description: |
The National Cancer Institute (NCI) intends to publish a Funding Opportunity Announcement (FOA) as a Request for Application (RFA) to solicit applications to build the Metastasis Research Network. This Notice is being provided to allow potential applicants time to develop responsive projects and meaningful collaborations. The FOA is expected to be published in April 2020 with expected application due dates in Summer 2020 and Winter 2021. The FOA will use the U54 activity code (Clinical Trial Not Allowed). Details of the planned FOAs are provided below. |
| Version: |
1 |
